These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12909472)

  • 1. Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
    Verleden GM; Dupont LJ; Van Raemdonck D; Vanhaecke J
    J Heart Lung Transplant; 2003 Aug; 22(8):908-13. PubMed ID: 12909472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation.
    Verleden GM; Dupont LJ; Van Raemdonck DE; Vanhaecke J;
    Transplantation; 2004 Sep; 78(5):730-3. PubMed ID: 15371677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled nitric oxide after lung transplantation: impact of the native lung.
    Verleden GM; Dupont LJ; Delcroix M; Van Raemdonck D; Vanhaecke J; Lerut T; Demedts M
    Eur Respir J; 2003 Mar; 21(3):429-32. PubMed ID: 12661996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome.
    Cairn J; Yek T; Banner NR; Khaghani A; Hodson ME; Yacoub M
    J Heart Lung Transplant; 2003 Jan; 22(1):50-7. PubMed ID: 12531413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross sectional study of exhaled nitric oxide levels following lung transplantation.
    Fisher AJ; Gabbay E; Small T; Doig S; Dark JH; Corris PA
    Thorax; 1998 Jun; 53(6):454-8. PubMed ID: 9713443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase.
    Gabbay E; Walters EH; Orsida B; Whitford H; Ward C; Kotsimbos TC; Snell GI; Williams TJ
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2182-7. PubMed ID: 11112135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical Trial of Inhaled Liposomal Cyclosporine Plus Standard-of-Care Versus Standard-of-Care Alone for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Iacono A; Wijesinha M; Völp A; Korotun M; Terrin M
    Ann Transplant; 2024 May; 29():e942823. PubMed ID: 38741362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
    Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F
    Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection.
    Silkoff PE; Caramori M; Tremblay L; McClean P; Chaparro C; Kesten S; Hutcheon M; Slutsky AS; Zamel N; Keshavjee S
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1822-8. PubMed ID: 9620912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-Release Tacrolimus Stabilizes Decline of Forced Expiratory Volume in 1 Second Through Decreasing Fluctuation of Its Trough Blood Level.
    Matsuda Y; Eba S; Hoshi F; Oishi H; Sado T; Noda M; Sakurada A; Watanabe T; Niikawa H; Akiba M; Okada Y
    Transplant Proc; 2018 Nov; 50(9):2768-2770. PubMed ID: 30401394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
    Sarahrudi K; Carretta A; Wisser W; Senbaklavaci O; Ploner M; Neuhauser P; Dobrovits M; Miwai Marta G; Papp A; Klepetko W
    Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation.
    Ross DJ; Lewis MI; Kramer M; Vo A; Kass RM
    Chest; 1997 Nov; 112(5):1175-9. PubMed ID: 9367453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in 25% to 75% forced expiratory flow as an early predictor of chronic airway rejection in pediatric lung transplant recipients.
    Rosen JB; Smith EO; Schecter MG; Mallory GB; Elidemir O
    J Heart Lung Transplant; 2012 Dec; 31(12):1288-92. PubMed ID: 23102913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled nitric oxide correlates with experimental lung transplant rejection.
    Mora BN; Boasquevisque CH; Uy G; McCarthy TJ; Welch MJ; Boglione M; Patterson GA
    Ann Thorac Surg; 2000 Jan; 69(1):210-5. PubMed ID: 10654515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
    Kesten S; Chaparro C; Scavuzzo M; Gutierrez C
    J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled nitric oxide and carbon monoxide in lung transplanted patients.
    Cameli P; Bargagli E; Fossi A; Bennett D; Voltolini L; Refini RM; Gotti G; Rottoli P
    Respir Med; 2015 Sep; 109(9):1224-9. PubMed ID: 26224473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.
    Meyer KC; Raghu G; Verleden GM; Corris PA; Aurora P; Wilson KC; Brozek J; Glanville AR; ;
    Eur Respir J; 2014 Dec; 44(6):1479-503. PubMed ID: 25359357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.
    Vos R; Vanaudenaerde BM; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Van Raemdonck DE; Schoonis A; Nawrot TS; Dupont LJ; Verleden GM
    Eur Respir J; 2011 Jan; 37(1):164-72. PubMed ID: 20562124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.